Tamil Nadu

Anna University was established on 4th September 1978 as a unitary type of University. It offers higher education in Engineering, Technology and allied Sciences relevant to the current and projected needs of the society.Besides promoting research and disseminating knowledge gained therefrom, it fosters cooperation between the academic and industrial communities.The University was formed by bringing together and integrating two well-known technical institutions in the city of Madras.

BIRAC’s University Innovation Cluster in Anna University funds and actively supports technically as well as professionally student entrepreneurs (See BIRAC Innovation Fellowships below) to establish their Biotech start-up. The attaractive fellowship is highly competitive. Motivated students with passion for innovation and drive for start-ups can apply with their business proposal to this UIC (see Scope & support of BIRAC Innovation Fellowship)

Post : Innovation Fellowship

ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support Clinical Development – from compound selection to Phase I - IV clinical studies ICON enjoys a strong reputation for quality and is focused on staff development. We make it our mission to attract the most diverse and creative minds into the business and we continually strive to provide opportunities for our people to excel, grow and build a great career. We understand that our greatest asset is the skills and talents of our people and they are truly what set us apart.

Post : Clinical Data Lead

Par Pharmaceutical merging the business with Endo's Qualitest, thereby expanding the generics business to a top five industry leader.  Endo is highly focused generics and specialty branded pharmaceutical company delivering quality medicines to patients in need through excellence in development, manufacturing and commercialization. Endo has global headquarters in Dublin, Ireland and U.S. headquarters in Malvern, PA.

Post : PHARMACEUTICAL PROFESSIONALS

The National Institute for Interdisciplinary Science and Technology (NIIST), Thiruvananthapuram, is a constituent Laboratory of the Council of Scientific and Industrial Research (CSIR). Initially established in 1975 as a CSIR Complex, it was named as the Regional Research Laboratory in 1978 and later renamed as NIIST in 2007.Its mandate is to conduct research and development activities of the highest quality in areas related to effective utilization of resources of the region and of fundamental importance to the country. Currently NIIST is engaged in R & D programmes in areas related to Agroprocessing, Chemical Sciences ,Materials Science and Technology.

This Institute invites eligible candidates for a Walk-in-interview for filling up the following purely temporary positions as detailed below

The Tuberculosis Research Centre (TRC), a permanent institute under the Indian Council of Medical Research (ICMR), is an internationally recognizAACed institution for Tuberculosis (TB) research. It is a Supranational Reference Laboratory and a WHO Collaborating Cenactrea for TB Research and Training. Recently, an International Centre for Excellence in Research (ICER) in collaboration with NIH was established at the Centre.

Applications are invited up to 17.04.2017 for the following posts to be filled purely on temporary basis under “STREAM STAGE II” Project and its sub-centres in Chennai, Vellore and Madurai, implemented by this Institute.

Thomson Reuters is the leading source of intelligent information for the world's businesses and professionals, providing customers with competitive advantage. Intelligent information is a unique synthesis of human intelligence, industry expertise and innovative technology that provides decision-makers with the knowledge to act, enabling them to make better decisions faster. Through its more than 50,000 people across 93 countries, Thomson Reuters delivers this must-have insight to the financial, legal, tax and accounting, scientific, healthcare and media markets, and is powered by the world's most trusted news organization.

Post : Associate Research Analyst/Research Analyst

{ DOWNLOAD AS PDF }

About Authors:
*R. Natarajan., Abirami. M, , Pavan kumar J, G. Murugananthan
Department of Pharmaceutics & research
Swamy Vivekanandha College of pharmacy
Tamil Nadu,  India
*svcpnatarajan@gmail.com

ABSTRACT
The work was carried out to formulate and evaluate the matrix transdermal patches of Lamivudine for the controlled delivery of drug in the body. The transdermal patches were prepared by the solvent casting method using Span-80 as a permeation enhancer and were prepared in different drug: polymer (Lamivudine: HPMC and Lamivudine: EC) ratios of 1:2.5, 1:5, without permeation enhancers and with permeation enhancers. The prepared transdermal patch were found to be good physicochemical properties, shows no skin irritation on the rat skin and  subjected to in vitro drug permeation study by using rat skin in phosphate buffer pH 7.4 for 24 hours. The comparative statistical analytical data (ANOVA) showed ‘p’ value < 0.0001 which suggest that the prepared formulation are extremely significant for transdermal delivery. The formulation (FPE2) ratio 1:5 of (Lamivudine: HPMC) patch with permeation enhancer showed best result among all the formulation. This formulation (FPE2) was subjected to in-vivo studies by using rat. The in-vivo studies of the patches were administrated transdermally to rat skin and while a standard solution of 10μg/ml was used as a control, and collected the plasma drug sample at different time interval and analyzed by HPLC. The in-vitro in-vivo correlation studies shows the regression value (R) 0.863 and correlated and to be linear.